Gene · 7398
Papers1,534
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,534
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| miRNA in head and neck squamous cell carcinomas: promising but still distant future of personalized oncology. | Rep Pract Oncol Radiother | 2023 | 38179293 | PubTator, text mining | PubMed |
| Therapeutic Consequences of Targeting the IGF-1/PI3K/AKT/FOXO3 Axis in Sarcopenia: A Narrative Review. | Cells | 2023 | 38132107 | PubTator, text mining | PubMed |
| New insights into the correlations between circulating tumor cells and target organ metastasis. | Signal Transduct Target Ther | 2023 | 38129401 | PubTator, text mining | PubMed |
| The ubiquitin thioesterase YOD1 ameliorates mutant Huntingtin induced pathology in Drosophila. | Sci Rep | 2023 | 38081944 | PubTator, text mining | PubMed |
| Integrated Single-Cell and Transcriptome Sequencing Analyses Develop a Ubiquitination-Associated Signature in Gastric Cancer and Identified OTULIN as a Novel Biomarker. | Front Biosci (Landmark Ed) | 2023 | 38062820 | PubTator, text mining | PubMed |
| Fanconi anemia pathway regulation by FANCI in prostate cancer. | Front Oncol | 2023 | 38023254 | PubTator, text mining | PubMed |
| Involvement of the OTUB1-YAP1 axis in driving malignant behaviors of head and neck squamous cell carcinoma. | Cancer Med | 2023 | 37986681 | PubTator, text mining | PubMed |
| Function, mechanism and drug discovery of ubiquitin and ubiquitin-like modification with multiomics profiling for cancer therapy. | Acta Pharm Sin B | 2023 | 37969742 | PubTator, text mining | PubMed |
| Proto-oncogene mutations in middle ear cholesteatoma contribute to its pathogenesis. | BMC Med Genomics | 2023 | 37968650 | PubTator, text mining | PubMed |
| Targeting the DNA Damage Response for Cancer Therapy. | Int J Mol Sci | 2023 | 37958890 | PubTator, text mining | PubMed |
| A combinatorial therapeutic approach to enhance FLT3-ITD AML treatment. | Cell Rep Med | 2023 | 37951217 | PubTator, text mining | PubMed |
| Inhibition of USP1 ameliorates hypertensive nephropathy through regulating oxidative stress and ferroptosis: A precise treatment via SJB3-019A nanodelivery. | Eur J Pharm Biopharm | 2023 | 37949326 | PubTator, text mining | PubMed |
| The Post-Translational Role of UFMylation in Physiology and Disease. | Cells | 2023 | 37947621 | PubTator, text mining | PubMed |
| Clinicopathological features of a rare cancer: Intrahepatic lymphoepithelioma-like cholangiocarcinoma with Epstein-Barr virus infection. | Clin Res Hepatol Gastroenterol | 2023 | 37944749 | PubTator, text mining | PubMed |
| Mesenchymal stem cells under epigenetic control - the role of epigenetic machinery in fate decision and functional properties. | Cell Death Dis | 2023 | 37932257 | PubTator, text mining | PubMed |
| Protein arginine methylation in viral infection and antiviral immunity. | Int J Biol Sci | 2023 | 37928266 | PubTator, text mining | PubMed |
| Plasma von Willebrand Factor Is Elevated Hyperacutely After Mild Traumatic Brain Injury. | Neurotrauma Rep | 2023 | 37908322 | PubTator, text mining | PubMed |
| DUBing Primary Tumors of the Central Nervous System: Regulatory Roles of Deubiquitinases. | Biomolecules | 2023 | 37892185 | PubTator, text mining | PubMed |
| Deubiquitylating Enzymes in Cancer and Immunity. | Adv Sci (Weinh) | 2023 | 37888853 | PubTator, text mining | PubMed |
| Targeting USP8 Inhibits O-GlcNAcylation of SLC7A11 to Promote Ferroptosis of Hepatocellular Carcinoma via Stabilization of OGT. | Adv Sci (Weinh) | 2023 | 37867237 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7398/papers?page=9